50881-013Level 3
MONJUVI (Tafasitamab-cxix)
**Product type:** Human Prescription Drug
**Active ingredient:** TAFASITAMAB
**Strength:** 200 mg/5mL
**Dosage form:** Injection, Powder, Lyophilized, For Solution
**Route:** Intravenous
**Labeler:** Incyte Corporation
**Marketing category:** BLA (BLA761163)
GET
/api/v1/systems/ndc_fda/nodes/50881-013Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.